Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Uninterrupted vs. interrupted OAC therapy | Metformin & polycystic kidney disease | Another approval for Abbott
Monday, April 12, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Uninterrupted OAC therapy for PCI patients leads to cost savings, shorter lengths of stay

Putting OAC therapy on hold does have its own benefits, the authors wrote, but uninterrupted OAC therapy is still the better choice. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Uninterrupted OAC therapy for PCI patients leads to cost savings, shorter lengths of stay

Share on Twitter Share on Facebook Share on Linkedin
Putting OAC therapy on hold does have its own benefits, the authors wrote, but uninterrupted OAC therapy is still the better choice. 
READ MORE >

Metformin shows promise for treating polycystic kidney disease

Typically used to treat Type 2 diabetes, metformin may also provide value as a treatment option for a serious, potentially fatal kidney disease. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Metformin shows promise for treating polycystic kidney disease

Share on Twitter Share on Facebook Share on Linkedin
Typically used to treat Type 2 diabetes, metformin may also provide value as a treatment option for a serious, potentially fatal kidney disease. 
READ MORE >

Abbott’s next-generation device for tricuspid heart valve repair gains CE mark approval

The device is only approved in the United States for investigational use at this time.

READ MORE >
approved approval
Share on Twitter Share on Facebook Share on Linkedin

Abbott’s next-generation device for tricuspid heart valve repair gains CE mark approval

Share on Twitter Share on Facebook Share on Linkedin
approved approval
The device is only approved in the United States for investigational use at this time.
READ MORE >

Featured Articles

‘An incredible discovery’: Researchers ID a gene that regenerates damaged muscles after a heart attack

“Our research has identified a secret switch that allows heart muscle cells to divide and multiply after the heart is injured," one researcher explained. "It kicks in when needed and turns off when the heart is fully healed."

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

‘An incredible discovery’: Researchers ID a gene that regenerates damaged muscles after a heart attack

Share on Twitter Share on Facebook Share on Linkedin
“Our research has identified a secret switch that allows heart muscle cells to divide and multiply after the heart is injured," one researcher explained. "It kicks in when needed and turns off when the heart is fully healed."
READ MORE >

Learn from an expert: How to limit cardiovascular disease among patients with diabetes

Rita Rastogi Kalyani, MD, an endocrinologist and associate professor at Johns Hopkins Medicine, shared her perspective on this crucial topic. 

READ MORE >
Rita Rastogi Kalyani, MD
Share on Twitter Share on Facebook Share on Linkedin

Learn from an expert: How to limit cardiovascular disease among patients with diabetes

Share on Twitter Share on Facebook Share on Linkedin
Rita Rastogi Kalyani, MD
Rita Rastogi Kalyani, MD, an endocrinologist and associate professor at Johns Hopkins Medicine, shared her perspective on this crucial topic. 
READ MORE >

New guidelines focus on the management of heart failure patients with secondary mitral regurgitation

The Heart Failure Association, European Association of Cardiovascular Imaging, European Heart Rhythm Association and European Association of Percutaneous Cardiovascular Interventions all collaborated on the position statement.

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

New guidelines focus on the management of heart failure patients with secondary mitral regurgitation

Share on Twitter Share on Facebook Share on Linkedin
women doctors
The Heart Failure Association, European Association of Cardiovascular Imaging, European Heart Rhythm Association and European Association of Percutaneous Cardiovascular Interventions all collaborated on the position statement.
READ MORE >

SGLT2 inhibitors reduce risk of atrial fibrillation, sudden cardiac death in patients with Type 2 diabetes

Researchers reviewed data from 34 different studies, covering a total of more than 63,000 patients.

READ MORE >
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Share on Twitter Share on Facebook Share on Linkedin

SGLT2 inhibitors reduce risk of atrial fibrillation, sudden cardiac death in patients with Type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Researchers reviewed data from 34 different studies, covering a total of more than 63,000 patients.
READ MORE >

From the Magazine

Better Together? An Integrated Market for Calcium-modification Strategies

Rather than a binary choice—atherectomy or lithotripsy—the market for treating severely calcified lesions seems likely to evolve into a mixture of both technologies. 

READ MORE >
 (OCT) intravascular images (bottom).
Share on Twitter Share on Facebook Share on Linkedin

Better Together? An Integrated Market for Calcium-modification Strategies

Share on Twitter Share on Facebook Share on Linkedin
 (OCT) intravascular images (bottom).
Rather than a binary choice—atherectomy or lithotripsy—the market for treating severely calcified lesions seems likely to evolve into a mixture of both technologies. 
READ MORE >

Succession Planning: Prepare Your Practice to Survive the Retirement Tsunami

Succession planning is about a practice’s top job, but it’s not *only* about the top job.

READ MORE >
succession_planning.png
Share on Twitter Share on Facebook Share on Linkedin

Succession Planning: Prepare Your Practice to Survive the Retirement Tsunami

Share on Twitter Share on Facebook Share on Linkedin
succession_planning.png
Succession planning is about a practice’s top job, but it’s not *only* about the top job.
READ MORE >

In Other News

Many women willing to pay more for screening MRI, particularly those with dense breasts

Only 34.7% of patients were happy with a mammography-only approach and many weren't worried about contrast imaging risks, according to a new single-center survey.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Many women willing to pay more for screening MRI, particularly those with dense breasts

Share on Twitter Share on Facebook Share on Linkedin
Only 34.7% of patients were happy with a mammography-only approach and many weren't worried about contrast imaging risks, according to a new single-center survey.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme